Pemetrexed Disodium Uses, Dosage, Side Effects and Interactions
Pemrydi Rtu
Pemrydi Rtu is a brand of pemetrexed disodium that comes as an injection. An FDA-approved generic with the same active ingredient is listed.
Alimta
Alimta was the first pemetrexed disodium product the FDA approved, in February 2004. An FDA-approved generic with the same active ingredient is listed.
Pemetrexed disodium is an intravenous chemotherapy medicine (a folate analog metabolic inhibitor) used to treat non-squamous non-small cell lung cancer and malignant pleural mesothelioma.
Quick links
Ask Anything About Pemetrexed DisodiumType a question in your own words. Answered from its FDA label in seconds.Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.
Pemetrexed Disodium in Short
- Drug class Folate Analog Metabolic Inhibitor How the FDA classifies it
What it treatsPemetrexed is used for non-squamous non-small cell lung cancer (NSCLC). It can be given with pembrolizumab and platinum chemotherapy, with cisplatin, or alone as maintenance or later treatment.
- How you get it Prescription only
- Comes asInjection (into a vein)Available strengths
- 100 mg/4 mL
- 100 mg/4.2 mL
- 100 mg/10 mL
- 500 mg/20 mL
- 500 mg/50 mL
- 750 mg/30 mL
See forms and strengths+ 3 more strengthsShow fewer strengths
- 1 g/40 mL
- 1000 mg/40 mL
- 1000 mg/100 mL
- Important safety informationWarnings and precautions Read the warnings and precautions for your exact product.
- Generic versionYes, FDA-approved Listed with the FDA, which does not mean every pharmacy stocks it
The Pharmacist’s Take
Pemetrexed (Alimta) is an IV chemotherapy for non-squamous non-small cell lung cancer and mesothelioma (cancer of the lung lining), a folate look-alike that blocks enzymes cancer cells need to build DNA and RNA; used since about 2004, with FDA-approved generics listed, it is a standard first treatment for both. Many people handle it better than they expect, with tiredness, nausea and poor appetite the usual complaints. The main danger is low blood counts (bone marrow suppression), which daily folic acid and vitamin B12 shots help prevent, so call your care team right away about fever or chills. Breathing trouble, blistering skin or little urine also need a prompt call.
Key Takeaways From the HelloPharmacist Team
- Take folic acid daily from a week before the first infusion until 21 days after the last, with a B12 shot every 3 cycles.
- Expect a 10-minute IV infusion every 21 days, plus dexamethasone, a steroid, by mouth the day before, day of and day after.
- Expect blood counts and kidney tests before every dose, and a delayed or reduced dose if counts run low.
- Don't reach for ibuprofen around infusion days without checking first, because it can raise pemetrexed levels, especially when kidney function is reduced.
Patient Information Guide for Pemetrexed Disodium
What It’s Used For
Pemetrexed is used for these cancers:
- Non-squamous non-small cell lung cancer, first treatment, with pembrolizumab and platinum chemotherapy (metastatic, no EGFR or ALK tumor changes)
- Non-squamous non-small cell lung cancer, first treatment, with cisplatin (locally advanced or metastatic)
- Non-squamous non-small cell lung cancer, maintenance treatment as a single agent after four cycles of platinum-based chemotherapy without progression
- Non-squamous non-small cell lung cancer, recurrent or metastatic, as a single agent after prior chemotherapy
- Malignant pleural mesothelioma, first treatment with cisplatin, when surgery to cure isn't an option
It is not for squamous cell lung cancer. Alimta, Pemrydi Rtu and pemetrexed injection labels all list these uses.
How It Works
Pemetrexed is a folate analog that blocks enzymes (thymidylate synthase, dihydrofolate reductase and GARFT) needed to make the building blocks of DNA. Cells take it in, and it is converted to forms that stay inside the cell. This disrupts the processes cells need to replicate.
Drug Class
Drug Class
- Folate Analog Metabolic Inhibitor
Detailed classifications and sources
The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class.
Drug Class
Established Pharmacologic Class (EPC)- Folate Analog Metabolic Inhibitor
The main drug class the FDA gives it. It is the class named on the drug’s label.
How It Works
Mechanism of action (MoA)- Folic Acid Metabolism Inhibitors
What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.
What It Does in the Body
Physiologic effect (PE)None listed for Pemetrexed Disodium in the FDA’s index.
From our Patient Information GuidePemetrexed is a folate analog that blocks enzymes (thymidylate synthase, dihydrofolate reductase and GARFT) needed to make the building blocks of DNA. Cells take it in, and it is converted to forms that stay inside the cell. Read How Pemetrexed Disodium Works
A change it makes in how the body works.
Chemical Family
Chemical structure (CS)None listed for Pemetrexed Disodium in the FDA’s index.
The chemical family it belongs to, by its structure.
Drug Family
WHO ATC classification- Folic acid analogues
How the World Health Organization groups it: by the part of the body it acts on and what it treats.
The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. The description under What It Does in the Body is written by the HelloPharmacist team, not the FDA. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.
Dosage
A healthcare professional gives pemetrexed as a 10-minute IV infusion on Day 1 of each 21-day cycle. Your prescriber and the label set the exact dose.
- Folic acid by mouth daily, from 7 days before the first dose until 21 days after the last
- Vitamin B12 injection 1 week before the first dose and every 3 cycles
- Dexamethasone by mouth the day before, day of and day after each dose
Since it is given at the clinic, ask your care team what to do if an appointment is missed.
Typical Doses
Your prescriber chooses your dose, so take it exactly as prescribed.
Lung cancer (non-squamous non-small cell)
Adults starting treatment with pembrolizumab and platinum chemotherapy Usual dose 500 mg/m2 on Day 1 of each 21-day cycle
- 500 mg/m2 as an intravenous infusion over 10 minutes, administered after pembrolizumab and prior to carboplatin or cisplatin on Day 1 of each 21-day cycle for 4 cycles
- Then pemetrexed with or without pembrolizumab until disease progression or unacceptable toxicity
Good to know
Creatinine clearance 45 mL/min or greater
Adults starting treatment with cisplatin Usual dose 500 mg/m2 on Day 1 of each 21-day cycle
- 500 mg/m2 as an intravenous infusion over 10 minutes administered prior to cisplatin on Day 1 of each 21-day cycle for up to six cycles in the absence of disease progression or unacceptable toxicity
Good to know
Creatinine clearance 45 mL/min or greater
Adults after four cycles of platinum-based chemotherapy · Maintenance treatment Usual dose 500 mg/m2 on Day 1 of each 21-day cycle
- 500 mg/m2 as an intravenous infusion over 10 minutes on Day 1 of each 21-day cycle until disease progression or unacceptable toxicity after four cycles of platinum-based first-line chemotherapy
Good to know
Creatinine clearance 45 mL/min or greater
Adults whose cancer returned after earlier chemotherapy · Treatment of recurrent disease Usual dose 500 mg/m2 on Day 1 of each 21-day cycle
- 500 mg/m2 as an intravenous infusion over 10 minutes on Day 1 of each 21-day cycle until disease progression or unacceptable toxicity
Good to know
Creatinine clearance 45 mL/min or greater
Mesothelioma (cancer of the lung lining)
For adults
Usual dose 500 mg/m2 on Day 1 of each 21-day cycle
- 500 mg/m2 as an intravenous infusion over 10 minutes on Day 1 of each 21-day cycle until disease progression or unacceptable toxicity
Good to know
Creatinine clearance 45 mL/min or greater
Folic acid premedication
For adults receiving pemetrexed
Usual dose 400 mcg to 1,000 mcg once a day
- 400 mcg to 1,000 mcg orally once daily, beginning 7 days before the first dose of pemetrexed and continuing until 21 days after the last dose
Vitamin B12 premedication
For adults receiving pemetrexed
Usual dose 1 mg of vitamin B12 by injection into muscle
- 1 mg intramuscularly, 1 week prior to the first dose of pemetrexed and every 3 cycles thereafter
Good to know
Do not substitute oral vitamin B12 for intramuscular vitamin B12
Dexamethasone premedication
For adults receiving pemetrexed
Usual dose 4 mg of dexamethasone twice a day
- 4 mg orally twice daily for three consecutive days, beginning the day before each pemetrexed administration
Myelosuppression: ANC less than 500/mm3 and platelets greater than or equal to 50,000/mm3, or platelets less than 50,000/mm3 without bleeding
For adults with low blood counts in the last cycle
75% of previous dose for next cycle
ANC stands for absolute neutrophil count.
Myelosuppression: platelet count less than 50,000/mm3 with bleeding
For adults 50% of previous dose for next cycleNon-hematologic toxicity: any grade 3 or 4 toxicities except mucositis or neurologic toxicity, or diarrhea requiring hospitalization
For adults 75% of previous dose for next cycleGrade 3 or 4 mucositis
For adults with severe mouth or gut lining sores 50% of previous dose for next cycleRenal toxicity
For adults with kidney side effects Withhold until creatinine clearance is 45 mL/min or greaterSpecial Situations
If side effects need a lower dose
Your doctor decides whether to lower your dose for side effects. Never change your dose on your own.
Recurrent grade 3 or 4 myelosuppression after 2 dose reductions
Discontinue
Side Effects
Common side effects include:
Common side effects
- Tiredness or fatigue
- Nausea
- Vomiting
- Loss of appetite
- Constipation
- Diarrhea
- Mouth or throat sores
- Low blood counts (anemia, low neutrophils, low platelets)
- Low red cells, white cells and platelets
- Rash, cough, shortness of breath and fever when given with pembrolizumab and platinum chemotherapy
When to get medical help
- Fever, chills or other signs of infection, which can happen when blood counts are low
- Little or no urine, or other signs of kidney problems
- Blistering, peeling or severe skin reactions
- New or worsening cough, trouble breathing or fever, which may signal lung inflammation (pneumonitis)
- Redness, inflammation or blistering in an area that was previously treated with radiation
- Severe allergic reaction
Call your care team about infection signs, trouble breathing, severe skin blistering or reduced urination.
Warnings and Precautions
- Bone marrow suppression: can cause severe low blood counts and infections. Vitamin supplementation reduces the risk.
- Kidney failure: can be severe and sometimes fatal. Kidney function is checked before each dose.
- Severe skin reactions: including Stevens-Johnson syndrome and toxic epidermal necrolysis.
- Interstitial pneumonitis: serious lung inflammation, sometimes fatal.
- Radiation recall: inflammation or blistering in previously irradiated areas.
- Fetal harm: can harm an unborn baby.
Interactions
A few medicines can raise pemetrexed levels.
- Ibuprofen: increases pemetrexed exposure, mostly a concern with reduced kidney function. Avoid it for 2 days before, the day of and 2 days after a dose if creatinine clearance is 45 to 79 mL/min.
- Other OAT3 inhibitors: avoid when possible, or expect closer monitoring.
Interactions Listed in the FDA-Approved Label
From the Pemetrexed Disodium prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.
-
What happensConcomitant use with an OAT3 inhibitor increases pemetrexed systemic exposure (AUC), which may increase the risk of adverse reactions.What to doAvoid ibuprofen for 2 days before, the day of, and 2 days following pemetrexed; if it cannot be avoided, monitor more frequently for myelosuppression, renal, and gastrointestinal toxicity.
-
Other OAT3 inhibitorsWhat happensPemetrexed is an OAT3 substrate; OAT3 inhibitors increase pemetrexed systemic exposure (AUC), which may increase the risk of adverse reactions.What to doAvoid before and after pemetrexed when possible; if it cannot be avoided, monitor patients more frequently for myelosuppression, renal, and gastrointestinal toxicity.
Read the label’s full interactions text
7 DRUG INTERACTIONS OAT3 Inhibitors: Modify the ibuprofen dosage as recommended. Avoid other OAT3 inhibitors. 7.1 Effects of Other Drugs on Pemetrexed Injection OAT3 Inhibitors Avoid concomitant administration of ibuprofen for 2 days before, the day of, and 2 days following administration of Pemetrexed Injection. Avoid concomitant administration of other OAT3 inhibitors before and after administration of Pemetrexed Injection, when possible. If concomitant administration cannot be avoided, monitor patients more frequently for myelosuppression, renal, and gastrointestinal toxicity. Pemetrexed is an OAT3 substrate. Concomitant use with an OAT3 inhibitor increases pemetrexed systemic exposure (AUC), which may increase the risk of Pemetrexed Injection adverse reactions.
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before You Start
- Severe allergic reaction to pemetrexed in the past means you shouldn't receive it.
- Kidney function below 45 mL/min means it should not be given.
- Low blood counts delay treatment.
- Pregnancy: can cause fetal harm. Use effective contraception.
- Breastfeeding: avoid during treatment and for one week after the last dose.
- Fertility: may impair fertility in men.
- Children: safety and effectiveness not established.
- Adults 65 and older: more severe low blood counts and fatigue seen in some trials.
Overdose
No drug is approved to treat pemetrexed overdose. Based on animal studies, leucovorin may help reduce its toxicities. It is not known whether dialysis removes pemetrexed.
Half-Life and How Your Body Processes It
Pemetrexed is given by IV, and its levels rise in proportion to the dose. It is not broken down much. About 70% to 90% leaves unchanged in the urine within 24 hours. The half-life is about 3.5 hours with normal kidney function. Reduced kidney function slows clearance and raises levels.
Storage
Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) .
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Pemetrexed Disodium: Pharmacist Answers to Common Questions
Quick, plain-English answers to the questions patients ask most about Pemetrexed Disodium — the kind of thing our pharmacy team would talk through with you at the counter.
What is pemetrexed used for?
How is pemetrexed given, and why do I need folic acid and B12?
What side effects should I expect?
When should I call my doctor?
Can I take ibuprofen while on pemetrexed?
Is pemetrexed safe in pregnancy?
Is pemetrexed disodium available over the counter?
When was pemetrexed disodium first available?
Who makes pemetrexed disodium?
What is the brand name of pemetrexed disodium?
What is the generic name of Pemrydi Rtu?
What drug class is pemetrexed disodium?
Is there a generic version of pemetrexed disodium?
What strengths does pemetrexed disodium come in?
Is there a pemetrexed disodium shortage?
Where can I read the pemetrexed disodium prescribing information (package insert)?
Is pemetrexed disodium gluten free?
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Ask Anything About Pemetrexed Disodium
Skip the scrolling. Ask in your own words and get an answer from Pemetrexed Disodium’s FDA label and our pharmacists’ own work.
Name another drug or a supplement in your question and we check both.
AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
- Sources: Pemetrexed Disodium’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
- Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
- Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
- Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.
More About Pemetrexed Disodium on HelloPharmacist
Still have a question? A licensed pharmacist answers for free, as soon as they can.Pemetrexed Disodium Forms and Strengths (How It Comes)
Pemetrexed Disodium comes in 1 dose form, the injection. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Pemetrexed Disodium inactive ingredients by manufacturer.
Injection
How this form is used
- Alimta is used for non-squamous non-small cell lung cancer and malignant pleural mesothelioma.
- Pemrydi Rtu is used for non-squamous non-small cell lung cancer and malignant pleural mesothelioma.
- Pemetrexed injection products are used for non-squamous non-small cell lung cancer and malignant pleural mesothelioma.
- Alimta is given as an IV infusion over 10 minutes on Day 1 of each 21-day cycle.
- Pemrydi Rtu is given as an IV infusion over 10 minutes on Day 1 of each 21-day cycle.
- With Alimta or Pemrydi Rtu, folic acid, vitamin B12 and dexamethasone are given alongside as directed.
Show 3 more strengths Show fewer strengths
Pemetrexed Disodium on the U.S. Market: Products, Makers and Brands
How Pemetrexed Disodium appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
14 companies list 42 Pemetrexed Disodium product records with the FDA, mostly as injection; the earliest marketing or approval year on record is 2004. Brand names in the directory today include Pemrydi Rtu and Alimta; the rest are generics.
Also listed with the FDA, not a patient dose form: Powder (15) · Unfinished injection (2) · Unfinished powder, for solution (2) — bulk drug substance and unfinished product sold to compounders and other manufacturers to finish, and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
How Widely Pemetrexed Disodium Is Used (Medicaid Data)
How many Pemetrexed Disodium prescriptions Medicaid paid for in Q1 2025 – Q1 2026, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.
How commonly is Pemetrexed Disodium prescribed? Of the 1,682 medications we measure, Pemetrexed Disodium ranks #1,022 by Medicaid prescriptions — more than 39% of them.
Source: Medicaid State Drug Utilization Data (CMS), all states. 19 of the 94 listed Pemetrexed Disodium NDCs had Medicaid claims.
Compare Pemetrexed Disodium Products
A representative set of FDA-listed product records for Pemetrexed Disodium — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Injection | ||||
| 100 mg/10 mL | Intravenous | Amneal Pharmaceuticals LLC | NDA | View NDC → |
| 500 mg/50 mL | Intravenous | Amneal Pharmaceuticals LLC | NDA | View NDC → |
| 1000 mg/100 mL | Intravenous | Amneal Pharmaceuticals LLC | NDA | View NDC → |
| 100 mg/4 mL | Intravenous | BluePoint Laboratories × 2 listings | ANDA | View NDC → |
| 500 mg/20 mL | Intravenous | BluePoint Laboratories × 2 listings | ANDA | View NDC → |
| 750 mg/30 mL | Intravenous | BluePoint Laboratories | ANDA | View NDC → |
| 1000 mg/40 mL | Intravenous | BluePoint Laboratories | ANDA | View NDC → |
| 100 mg/4 mL | Intravenous | Camber Pharmaceuticals, Inc. | ANDA | View NDC → |
| 500 mg/20 mL | Intravenous | Camber Pharmaceuticals, Inc. | ANDA | View NDC → |
| 100 mg/4 mL | Intravenous | Dr. Reddys Laboratories Inc | ANDA | View NDC → |
| 500 mg/20 mL | Intravenous | Dr. Reddys Laboratories Inc | ANDA | View NDC → |
| 1 g/40 mL | Intravenous | Dr. Reddys Laboratories Inc | ANDA | View NDC → |
| 100 mg/4 mL | Intravenous | Eli Lilly and Company | NDA | View NDC → |
| 500 mg/20 mL | Intravenous | Eli Lilly and Company | NDA | View NDC → |
| 100 mg/4 mL | Intravenous | Fresenius Kabi USA, LLC | ANDA | View NDC → |
| 500 mg/20 mL | Intravenous | Fresenius Kabi USA, LLC | ANDA | View NDC → |
| 750 mg/30 mL | Intravenous | Fresenius Kabi USA, LLC | ANDA | View NDC → |
| 1 g/40 mL | Intravenous | Fresenius Kabi USA, LLC | ANDA | View NDC → |
| 100 mg/4.2 mL | Intravenous | Meitheal Pharmaceuticals Inc. | ANDA | View NDC → |
| 100 mg/10 mL | Intravenous | Meitheal Pharmaceuticals Inc. | ANDA | View NDC → |
| 500 mg/20 mL | Intravenous | Meitheal Pharmaceuticals Inc. | ANDA | View NDC → |
| 500 mg/50 mL | Intravenous | Meitheal Pharmaceuticals Inc. | ANDA | View NDC → |
| 750 mg/30 mL | Intravenous | Meitheal Pharmaceuticals Inc. | ANDA | View NDC → |
| 1 g/40 mL | Intravenous | Meitheal Pharmaceuticals Inc. | ANDA | View NDC → |
| 100 mg/10 mL | Intravenous | NorthStar RxLLC | ANDA | View NDC → |
| 500 mg/50 mL | Intravenous | NorthStar RxLLC | ANDA | View NDC → |
| 100 mg/4 mL | Intravenous | Qilu Pharmaceutical Co., Ltd. | ANDA | View NDC → |
| 500 mg/20 mL | Intravenous | Qilu Pharmaceutical Co., Ltd. | ANDA | View NDC → |
| 100 mg/4.2 mL | Intravenous | Sagent Pharmaceuticals | ANDA | View NDC → |
| 500 mg/20 mL | Intravenous | Sagent Pharmaceuticals | ANDA | View NDC → |
| 100 mg/4 mL | Intravenous | Sandoz Inc. | NDA | View NDC → |
| 500 mg/20 mL | Intravenous | Sandoz Inc. | NDA | View NDC → |
| 1000 mg/40 mL | Intravenous | Sandoz Inc. | NDA | View label ↗ |
| 100 mg/10 mL | Intravenous | Shilpa Medicare Limited | NDA | View NDC → |
| 500 mg/50 mL | Intravenous | Shilpa Medicare Limited | NDA | View NDC → |
| 1000 mg/100 mL | Intravenous | Shilpa Medicare Limited | NDA | View NDC → |
| 100 mg/4 mL | Intravenous | Somerset Therapeutics LLC | ANDA | View NDC → |
| 500 mg/20 mL | Intravenous | Somerset Therapeutics LLC | ANDA | View NDC → |
| 100 mg/4 mL | Intravenous | Waverley Pharma Inc | ANDA | View NDC → |
| 500 mg/20 mL | Intravenous | Waverley Pharma Inc | ANDA | View NDC → |
Showing 42 of 42 products — FDA National Drug Code Directory. See every product, package size and price: browse all 42 Pemetrexed Disodium NDCs →
Pemetrexed Disodium Side Effects Reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Pemetrexed Disodium — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Pemetrexed Disodium in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Pemetrexed Disodium FDA Approval History
How Pemetrexed Disodium went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
Pemetrexed Disodium Recall History
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list one Pemetrexed Disodium recall since July 2021, covering 2 product listings. It is still ongoing. A recall names specific lots from one company, so check the lot number on your own bottle rather than assuming every product is affected; your pharmacist can check whether your supply came from an affected lot.
- PEMRYDI RTU(pemetrexed injection), 500 mg/50 mL (10 mg/mL), Single-dose vial, Rx only, Manufactured by: Zydus Lifesciences Limited, Ahmedabad, India; Distributed by: Amneal Pharmaceuticals LC, Bridge… Lots: Lot: P400157, Exp 08/31/2026; Lot PA00047A, Exp 09/30/2027 FDA record D-0765-2026 →
- PEMRYDI RTU (pemetrexed injection), 100 mg/10 mL (10 mg/mL), Single-dose vial, Rx only, Manufactured by: Zydus Lifesciences Limited, Ahmedabad, India; Distributed by: Amneal Pharmaceuticals LC, Bridg… Lots: Lot: P400172; Lot PA00050A, Exp 09/30/2027 FDA record D-0764-2026 →
Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.
Pemetrexed Disodium Supply and Shortage Status
Whether Pemetrexed Disodium is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
Pemetrexed Disodium Brand Names
Pemetrexed Disodium has 2 brand names on record: Pemrydi Rtu and Alimta. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.
Who Makes Pemetrexed Disodium: Manufacturers and Labelers
14 companies list Pemetrexed Disodium products with the FDA. By number of product records, the largest are BluePoint Laboratories, Meitheal Pharmaceuticals Inc., Fresenius Kabi USA, LLC. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
Sources for This Pemetrexed Disodium Page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Sandoz Inc. is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →